APA (7th ed.) Citation

RJ, B., A, M., PI, R., FM, D., S, N., M, P., . . . GD, W. (2005). Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British journal of cancer, 92(1), 147. https://doi.org/10.1038/sj.bjc.6602256

Chicago Style (17th ed.) Citation

RJ, Burcombe, et al. "Evaluation of ER, PgR, HER-2 and Ki-67 as Predictors of Response to Neoadjuvant Anthracycline Chemotherapy for Operable Breast Cancer." British Journal of Cancer 92, no. 1 (2005): 147. https://doi.org/10.1038/sj.bjc.6602256.

MLA (9th ed.) Citation

RJ, Burcombe, et al. "Evaluation of ER, PgR, HER-2 and Ki-67 as Predictors of Response to Neoadjuvant Anthracycline Chemotherapy for Operable Breast Cancer." British Journal of Cancer, vol. 92, no. 1, 2005, p. 147, https://doi.org/10.1038/sj.bjc.6602256.